Topic 338 phase i sbir defining normal tissue and tumor biomarkers of radiosenstivity to detect treatment

Ended Definitive Contract Awarded Last action

Contract number
HHSN261201500042C
Awardee
Awarding agency
Obligated
$299,957

Award facts

Opportunity
  • N43CO5102338 Solicitation number
Contract value 100% obligated
$299,957.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
New Haven, CT 06511, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $299,957

About this award

This is a federal contract award to Mira DX Inc., a woman-owned small business, by the National Cancer Institute. The contract has a ceiling value of $299,957.00 and is a definitive, firm-fixed-price contract. The contract was set aside for total small business and the original solicitation is not provided. The place of performance is Hamden, CT. The contract was awarded on September 22, 2015 with a final completion date of September 15, 2016.

Quick answers

Who was awarded contract HHSN261201500042C?

HHSN261201500042C was awarded to Mira DX Inc. by National Cancer Institute (National Institutes of Health) on September 22, 2015.

How much is contract HHSN261201500042C worth?

The government has obligated $299,957 on HHSN261201500042C.

Was contract HHSN261201500042C competed?

The extent of competition for HHSN261201500042C was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award